Patients with severe infections should be treated with beta-lactam-beta-lactamase inhibitor combinations (e.g., ampicillin-sulbactam, piperacillin-tazobactam) or carbapenems (e.g., imipenem, meropenem) while awaiting susceptibility test results. The gene discussed is LACTB; the disease is infection.